Eiji Miyauchi

Title: Eiji Miyauchi: Innovator in Immune-Enhancing Agents

Introduction

Eiji Miyauchi is a notable inventor based in Wako, Japan. He has made significant contributions to the field of immune-enhancing agents, holding a total of 2 patents. His work focuses on developing innovative solutions that improve health outcomes through enhanced immune responses.

Latest Patents

Miyauchi's latest patents include a Type 1 helper T cell-increasing agent and an intestinal immune-enhancing agent. The Type 1 helper T cell-increasing agent aims to provide a Th1-increasing agent that can reduce constraints on storage conditions and feeding form while sufficiently increasing Th1 at lower doses. This agent contains a cellulose derivative as an active ingredient, which has a degree of butyryl substitution of 0.3 or greater and 2.6 or less, along with a total degree of substitution of 0.5 or greater and 2.8 or less. The intestinal immune-enhancing agent is designed to sufficiently increase IgA in the intestinal tract with a low dose while maintaining an increased amount of IgA for an extended period. This agent contains a cellulose acetate that has a total degree of acetyl substitution from 0.4 to 1.1.

Career Highlights

Eiji Miyauchi is currently employed at Daicel Corporation, where he continues to innovate in the field of pharmaceuticals and food products. His work is characterized by a commitment to enhancing immune function through scientifically-backed solutions.

Collaborations

Miyauchi collaborates with esteemed colleagues such as Hiroshi Ohno and Tadashi Takeuchi, contributing to a dynamic research environment that fosters innovation.

Conclusion

Eiji Miyauchi's contributions to the development of immune-enhancing agents reflect his dedication to improving health through innovative inventions. His patents demonstrate a significant advancement in the field, showcasing the potential for enhanced immune responses in both food and pharmaceutical applications.